Adolescent HPV vaccination: empowerment, equity and ethics

References

• World Health Organization. Human papillomavirus vaccines: WHO position paper, May 2017. Releve Epidemiologique Hebdomadaire. 2017;92(19):241–68.
   PubMedGoogle Scholar
• Jit M, Brisson M, Portnoy A, Hutubessy R. Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study. Lancet Global Health. 2014;2(7):e406–414. doi:10.1016/S2214-109X(14)70237-2.
   PubMed Web of Science ®Google Scholar
• Bruni L, Diaz M, Barrionuevo-Rosas L, Herrero R, Bray F, Bosch FX, de Sanjosé S, Castellsagué X, et al. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Global Health. 2016;4(7):e453–463. doi:10.1016/S2214-109X(16)30099-7.
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. [accessed 2018 Jan 04] http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
   Google Scholar
• de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Nt J Cancer. 2017;141(4):664–70. doi:10.1002/ijc.v141.4.
   PubMed Web of Science ®Google Scholar
• Howard N, Gallagher KE, Mounier-Jack S, Burchett HED, Kabakama S, LaMontagne DS, Watson-Jones D, et al. What works for human papillomavirus vaccine introduction in low and middle-income countries? Papillomavirus Res. 2017;4:22–25. doi:10.1016/j.pvr.2017.06.003.
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Tsu V, Deeks SL, Cubie H, Wang SA, Vicari AS, Brotherton JML, et al. Human papillomavirus vaccine introduction–the first five years. Vaccine. 2012;30(Suppl 5):F139–148. doi:10.1016/j.vaccine.2012.05.039.
   PubMed Web of Science ®Google Scholar
• Ferrer HB, Trotter C, Hickman M, Audrey S. Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis. BMC Public Health. 2014;14:700. doi:10.1186/1471-2458-14-700.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Considerations regarding consent in vaccinating children and adolescents between 6 and 17 years old. 2014; [accessed 2018 Jan 01]. http://www.who.int/immunization/programmes_systems/policies_strategies/consent_note_en.pdf.
   Google Scholar
• English A, Ford CA, Kahn JA, Kharbanda EO, Middleman AB. Adolescent consent for vaccination: a position paper of the society for adolescent health and medicine. J Adolesc Health off Publ Soc Adolesc Med. 2013;53:550–53.
   PubMedGoogle Scholar
• Nathawad R, Goldhagen J. A child rights and equity-based framework to advance policy and practice related to adolescent consent to vaccines. J Adolesc Health off Publ Soc Adolesc Med. 2014;54(5):619. doi:10.1016/j.jadohealth.2014.02.007.
   PubMed Web of Science ®Google Scholar
• United Nations General Assembly. Res 44/25, convention on the rights of the child. 1989; Accessed 2013 Dec 24. http://www.un.org/documents/ga/res/44/a44r025.htm.
   Google Scholar
• Malmqvist E, Helgesson G, Lehtinen J, Natunen K, Lehtinen M. The ethics of implementing human papillomavirus vaccination in developed countries. Med Health Care Philos. 2011;14(1):19–27. doi:10.1007/s11019-010-9285-9.
   PubMed Web of Science ®Google Scholar
• Thompson A. Human papilloma virus, vaccination and social justice: an analysis of a Canadian school-based vaccine program. Public Health Ethics. 2013;6(1):11–20. doi:10.1093/phe/pht010.
   Web of Science ®Google Scholar
• Agrawal S, Morain SR. Who calls the shots? The ethics of adolescent self-consent for HPV vaccination. J Med Ethics. 2018. doi:10.1136/medethics-2017-104694.
   PubMed Web of Science ®Google Scholar
• Audrey S, Batista Ferrer H, Ferrie J, Evans K, Bell M, Yates J, Roderick M, MacLeod J, Hickman M, et al. Impact and acceptability of self-consent procedures for the school-based human papillomavirus vaccine: a mixed-methods study protocol. BMJ Open. 2018;8:3. doi:10.1136/bmjopen-2017-021321.
   Web of Science ®Google Scholar
• Katahoire AR, Wani JA, Murokora D, Mugisha E, LaMontagne DS. Acceptability of HPV vaccine among young adolescent girls in Uganda: young people’s perspectives count. Int J Child Adolesc Health. 2013;6:211.
   Google Scholar
• Rylance G, Bowen C, Rylance J. Measles and rubella immunisation: information and consent in children. BMJ. 1995;311(7010):923–24. doi:10.1136/bmj.311.7010.923.
   PubMedGoogle Scholar
• Hein IM, De Vries MC, Troost PW, Meynen G, Van Goudoever JB, Lindauer RJ. Informed consent instead of assent is appropriate in children from the age of twelve: policy implications of new findings on children’s competence to consent to clinical research. BMC Med Ethics. 2015;16(1):76. doi:10.1186/s12910-015-0067-z.
   PubMed Web of Science ®Google Scholar
• Salter EK. Conflating capacity and authority: why we’re asking the wrong question in the adolescent decision-making debate. Hastings Center Report. 2017;47(1):32–41. doi:10.1002/hast.666.
   PubMed Web of Science ®Google Scholar
• Coleman DL, Rosoff PM. The legal authority of mature minors to consent to general medical treatment. Pediatrics. 2013;131(4):786–93. doi:10.1542/peds.2012-2470.
   PubMed Web of Science ®Google Scholar
• Patel H, Jeve YB, Sherman SM, Moss EL. Knowledge of human papillomavirus and the human papillomavirus vaccine in European adolescents: a systematic review. Sex Transm Infect. 2016;92(6):474–79. doi:10.1136/sextrans-2015-052341.
   PubMed Web of Science ®Google Scholar
• Salwa M, Abdullah Al-Munim T. Ethical issues related to human papillomavirus vaccination programs: an example from Bangladesh. BMC Med Ethics. 2018;19(Suppl 1):39. doi:10.1186/s12910-018-0287-0.
   PubMedGoogle Scholar
• Braunack-Mayer A, Skinner SR, Collins J, Tooher R, Proeve C, O’Keefe M, Burgess T, Watson M, Marshall H, et al. Ethical challenges in school-based immunization programs for adolescents: a qualitative study. Am J Public Health. 2015;105(7):1399–403. doi:10.2105/AJPH.2014.302280.
   PubMed Web of Science ®Google Scholar
• Kabakama S, Gallagher KE, Howard N, Mounier-Jack S, Burchett HED, Griffiths UK, Feletto M, LaMontagne DS, Watson-Jones D, et al. Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries. BMC Public Health. 2016;16(1):834. doi:10.1186/s12889-016-3517-8.
   PubMedGoogle Scholar
• Brabin L, Roberts SA, Stretch R, Baxter D, Elton P, Kitchener H, McCann R, et al. A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study. Br J Cancer. 2009;101(9):1502–04. doi:10.1038/sj.bjc.6605362.
   PubMed Web of Science ®Google Scholar
• Buttery JP, Madin S, Crawford NW, Elia S, La Vincente S, Hanieh S, Smith L, Bolam B, et al. Mass psychogenic response to human papillomavirus vaccination. Med J Aust. 2008;189(5):261–62. doi:10.5694/mja2.2008.189.issue-5.
   PubMed Web of Science ®Google Scholar
• Domingues CMAS, AGK M, Pinto MFS. The introduction of HPV vaccines in Brazil: advances and challenges. DST - J Bras Doenças Sex Transm. 2015;27:67–72.
   Google Scholar
• Rambout L, Tashkandi M, Hopkins L, Tricco AC. Self-reported barriers and facilitators to preventive human papillomavirus vaccination among adolescent girls and young women: a systematic review. Prev Med. 2014;58:22–32. doi:10.1016/j.ypmed.2013.10.009.
   PubMed Web of Science ®Google Scholar
• Pourat N, Jones JM. Role of insurance, income, and affordability in human papillomavirus vaccination. Am J Manag Care. 2012;18:320–30.
   PubMed Web of Science ®Google Scholar
• Crowcroft NS, Hamid JS, Deeks SL, Frank J. Human papilloma virus vaccination programs reduce health inequity in most scenarios: a simulation study. BMC Public Health. 2012;12:935. doi:10.1186/1471-2458-12-935.
   PubMed Web of Science ®Google Scholar
• Brisson M, Benard É, Drolet M, Bogaards JA, Baussano I, Vänskä S, Jit M, Boily M-C, Smith MA, Berkhof J, et al. Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models. Lancet Public Health. 2016;1(1):e8–e17. doi:10.1016/S2468-2667(16)30001-9.
   PubMed Web of Science ®Google Scholar
• Ben Hadj Yahia MB, Jouin-Bortolotti A, Dervaux B. Extending the human papillomavirus vaccination programme to include males in high-income countries: a systematic review of the cost-effectiveness studies. Clin Drug Investig. 2015;35(8):471–85. doi:10.1007/s40261-015-0308-4.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Gauthier A, Postma MJ, Ribassin-Majed L, Largeron N, Bresse X. A critical review of cost-effectiveness analyses of vaccinating males against human papillomavirus. Hum Vaccin Immunother. 2013;9(11):2285–95. doi:10.4161/hv.25754.
   PubMed Web of Science ®Google Scholar
• Sonawane K, Suk R, Chiao EY, Chhatwal J, Qiu P, Wilkin T, Nyitray AG, Sikora AG, Deshmukh AA, et al. Oral human papillomavirus infection: differences in prevalence between sexes and concordance with genital human papillomavirus infection, nhanes 2011 to 2014. Ann Intern Med. 2017;167(10):714–24. doi:10.7326/M17-1363.
   PubMed Web of Science ®Google Scholar
• van den Hoven M. Why one should do one’s bit: thinking about free riding in the context of public health ethics. Public Health Ethics. 2012;5(2):154–60. doi:10.1093/phe/phs023.
   Web of Science ®Google Scholar
• Kumakech E, Andersson S, Wabinga H, Musubika C, Kirimunda S, Berggren V. Cervical cancer risk perceptions, sexual risk behaviors and sexually transmitted infections among Bivalent Human Papillomavirus vaccinated and non-vaccinated young women in Uganda - 5 year follow up study. BMC Women Health. 2017;17(1):40. doi:10.1186/s12905-017-0394-y.
   PubMedGoogle Scholar
• Mullins TLK, Rosenthal SL, Zimet GD, Ding L, Morrow C, Huang B, Kahn JA. Human vaccine-related risk perceptions do not predict sexual initiation among young women over 30 months following vaccination. J Adolesc Health. 2018;62(2):164–9. doi:10.1016/j.jadohealth.2017.09.008.
   Google Scholar
• Noakes K, Yarwood J, Salisbury D. Parental response to the introduction of a vaccine against human papilloma virus. Hum Vaccin. 2006;2(6):243–48. doi:10.4161/hv.2.6.3391.
   PubMed Web of Science ®Google Scholar
• Turiho AK, Okello ES, Muhwezi WW, Harvey S, Byakika-Kibwika P, Meya D, Katahoire AR, et al. Effect of School-based Human Papillomavirus (HPV) vaccination on adolescent girls’ knowledge and acceptability of the HPV vaccine in Ibanda district in Uganda. Afr J Reprod Health. 2014;18(4):45–53.
   PubMed Web of Science ®Google Scholar